Literature DB >> 25593263

Complete Genome Sequence of Citrobacter freundii Myophage Miller.

Kyuwon Hwang1, Adrian J Luna1, Adriana C Hernandez1, Gabriel F Kuty Everett2.   

Abstract

Citrobacter freundii is a Gram-negative, opportunistic pathogen that can be fatal to newborns or immunocompromised patients. Bacteriophages against this bacterium can be useful for therapeutic purposes. Here, we describe the complete genome and the key features of the pseudo T-even C. freundii bacteriophage Miller.
Copyright © 2015 Hwang et al.

Entities:  

Year:  2015        PMID: 25593263      PMCID: PMC4299905          DOI: 10.1128/genomeA.01425-14

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Citrobacter freundii is a Gram-negative ubiquitous bacterium. It is a member of the family Enterobacteriaceae and is associated with fatal neonatal meningitis and various nosocomial infections (1). The treatment of such conditions is difficult due to the broad range of antibiotic resistance expressed by many strains of the bacterium (2). Moreover, it has been proposed that the C  freundii may play a role in disseminating antibiotic resistance genes to other microbial communities in soil (3). Bacteriophages against C. freundii could be used to quell the growing problem of this pathogenic bacterium. Bacteriophage Miller was isolated from a sewage sample collected in Bryan, TX, USA. Phage DNA was sequenced in an Illumina MiSeq 250-bp paired-end run with a 550-bp insert library at the Genomic Sequencing and Analysis Facility at the University of Texas (Austin, TX, USA). Quality controlled, trimmed reads were assembled to a single contig at 30.1 fold coverage using Velvet version 1.2.10. Contigs were confirmed to be complete by PCR. Genes were predicted using GeneMarkS (4) and corrected using software tools available on the Center for Phage Technology (CPT) Galaxy instance (https://cpt.tamu.edu/galaxy-public/). Morphology was determined using transmission electron microscopy performed at the Texas A&M University Microscopy and Imaging Center. Miller is an RB43-like, morphotype A2 myophage that shares 88.2% homology with RB43 (NC_007023) as determined by Emboss Stretcher (5, 6). The genomic differences are largely attributed to hypothetical conserved/novel genes of unknown function. Unlike RB43, which has a fused rIIa and rIIb gene, Miller has separate rIIa and rIIb genes that share an overlapping start/stop codon. As with RB43 and other pseudo T-even phages, the genome of Miller is opened to rIIb (7). Miller has a 178,171-base pair genome, a coding density of 95.6%, 43.13% G+C content, and 277 predicted genes. The G+C content is comparable to RB43 (43.2%). Of the 277 predicted coding sequences, 170 are hypothetical conserved/novel, and 99 were given a putative function based on BLASTp and InterPro analysis (8, 9). Miller encodes one homing endonuclease with an AP2 DNA-binding domain compared to the three AP2 domain containing HNH homing endonucleases of RB43. Like RB43, Miller encodes a single tRNA gene. In RB43, the tRNA is an Ile where as in Miller, it is a Met as has been reported in RB43-like Escherichia coli phage Lw1 (7). Overall, the genome of Miller is syntenic with that of RB43. Pseudo T-even-like genes encoding the proteins for biosynthesis, DNA replication, recombination, morphogenesis, DNA packaging, and lysis were annotated. A T-even-like lysis cassette was identified including a class III holin, inner and outer membrane spanins, an rI-like antiholin, and an endolysin. Unlike T4, which encodes a muraminidase (EC 3.2.1.17); the endolysin of Miller is a peptidase (EC 3.4.16.4) as with other RB43-like phages. An additional peptidoglycan-binding protein was identified by its LysM domain (IPR018392), but the role of this protein in the page infection is unknown.

Nucleotide sequence accession number.

The genome sequence of phage Miller was contributed as accession no. KM236237 to GenBank.
  9 in total

1.  GeneMarkS: a self-training method for prediction of gene starts in microbial genomes. Implications for finding sequence motifs in regulatory regions.

Authors:  J Besemer; A Lomsadze; M Borodovsky
Journal:  Nucleic Acids Res       Date:  2001-06-15       Impact factor: 16.971

Review 2.  A catalogue of T4-type bacteriophages.

Authors:  H W Ackermann; H M Krisch
Journal:  Arch Virol       Date:  1997       Impact factor: 2.574

3.  Optimal alignments in linear space.

Authors:  E W Myers; W Miller
Journal:  Comput Appl Biosci       Date:  1988-03

4.  Citrobacter freundii invades and replicates in human brain microvascular endothelial cells.

Authors:  J L Badger; M F Stins; K S Kim
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

5.  BLAST+: architecture and applications.

Authors:  Christiam Camacho; George Coulouris; Vahram Avagyan; Ning Ma; Jason Papadopoulos; Kevin Bealer; Thomas L Madden
Journal:  BMC Bioinformatics       Date:  2009-12-15       Impact factor: 3.169

6.  Distribution of tetracycline and streptomycin resistance genes and class 1 integrons in Enterobacteriaceae isolated from dairy and nondairy farm soils.

Authors:  Velusamy Srinivasan; Hyang-Mi Nam; Ashish A Sawant; Susan I Headrick; Lien T Nguyen; Stephen P Oliver
Journal:  Microb Ecol       Date:  2007-08-15       Impact factor: 4.552

7.  Complex integrons containing qnrB4-ampC (bla(DHA-1)) in plasmids of multidrug-resistant Citrobacter freundii from wastewater.

Authors:  Grace Yim; Waldan Kwong; Julian Davies; Vivian Miao
Journal:  Can J Microbiol       Date:  2012-11-29       Impact factor: 2.419

8.  Complete Genome Sequence of Escherichia Phage Lw1, a New Member of the RB43 Group of Pseudo T-Even Bacteriophages.

Authors:  Alla I Kushkina; Fedor I Tovkach; André M Comeau; Igor E Kostetskii; Igor Lisovski; Andriy M Ostapchuk; Sergiy I Voychuk; Tetiana I Gorb; Liudmyla V Romaniuk
Journal:  Genome Announc       Date:  2013-12-12

9.  InterPro: the integrative protein signature database.

Authors:  Sarah Hunter; Rolf Apweiler; Teresa K Attwood; Amos Bairoch; Alex Bateman; David Binns; Peer Bork; Ujjwal Das; Louise Daugherty; Lauranne Duquenne; Robert D Finn; Julian Gough; Daniel Haft; Nicolas Hulo; Daniel Kahn; Elizabeth Kelly; Aurélie Laugraud; Ivica Letunic; David Lonsdale; Rodrigo Lopez; Martin Madera; John Maslen; Craig McAnulla; Jennifer McDowall; Jaina Mistry; Alex Mitchell; Nicola Mulder; Darren Natale; Christine Orengo; Antony F Quinn; Jeremy D Selengut; Christian J A Sigrist; Manjula Thimma; Paul D Thomas; Franck Valentin; Derek Wilson; Cathy H Wu; Corin Yeats
Journal:  Nucleic Acids Res       Date:  2008-10-21       Impact factor: 16.971

  9 in total
  5 in total

Review 1.  The Microbiome in Pancreatic Cancer-Implications for Diagnosis and Precision Bacteriophage Therapy for This Low Survival Disease.

Authors:  Mwila Kabwe; Stuart Dashper; Joseph Tucci
Journal:  Front Cell Infect Microbiol       Date:  2022-05-19       Impact factor: 6.073

2.  Genomic, Morphological and Functional Characterization of Virulent Bacteriophage IME-JL8 Targeting Citrobacter freundii.

Authors:  Kaixiang Jia; Nuo Yang; Xiuwen Zhang; Ruopeng Cai; Yang Zhang; Jiaxin Tian; Sayed Haidar Abbas Raza; Yuanhuan Kang; Aidong Qian; Ying Li; Wuwen Sun; Jinyu Shen; Jiayun Yao; Xiaofeng Shan; Lei Zhang; Guiqin Wang
Journal:  Front Microbiol       Date:  2020-11-19       Impact factor: 5.640

3.  The Bacteriophage vB_CbrM_HP1 Protects Crucian Carp Against Citrobacter braakii Infection.

Authors:  Chunzheng Huang; Chao Feng; Xiao Liu; Rihong Zhao; Zijing Wang; Hengyu Xi; Hongda Ou; Wenyu Han; Zhimin Guo; Jingmin Gu; Lei Zhang
Journal:  Front Vet Sci       Date:  2022-05-06

4.  Characterization of Five Podoviridae Phages Infecting Citrobacter freundii.

Authors:  Sana Hamdi; Geneviève M Rousseau; Simon J Labrie; Rim S Kourda; Denise M Tremblay; Sylvain Moineau; Karim B Slama
Journal:  Front Microbiol       Date:  2016-06-29       Impact factor: 5.640

5.  Isolation and Characterization of Bacteriophages That Infect Citrobacter rodentium, a Model Pathogen for Intestinal Diseases.

Authors:  Carolina M Mizuno; Tiffany Luong; Robert Cederstrom; Mart Krupovic; Laurent Debarbieux; Dwayne R Roach
Journal:  Viruses       Date:  2020-07-08       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.